Intraoperative reported adverse events in children

被引:19
|
作者
Kakavouli, Athina
Li, Guohua [2 ]
Carson, Margaret P.
Sobol, Julia
Lin, Christine
Ohkawa, Susumu
Huang, Lin [3 ]
Galiza, Carolyn
Wood, Alastair [5 ,6 ,7 ,8 ]
Sun, Lena S. [1 ,4 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10032 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, Dept Anesthesiol, New York, NY 10032 USA
[3] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA
[4] Columbia Univ, Dept Pediat, New York, NY 10032 USA
[5] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA
[6] Weill Cornell Med Coll, Dept Internal Med, New York, NY USA
[7] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
[8] Vanderbilt Univ, Dept Internal Med, Nashville, TN USA
关键词
anesthesia; pediatric; adverse events; operating room anesthesia; nonoperating room anesthesia; PEDIATRIC PROCEDURAL SEDATION; OPERATING-ROOM; SEDATION/ANESTHESIA; PROPOFOL;
D O I
10.1111/j.1460-9592.2009.03066.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Significant intraprocedural adverse events (AE) are reported in children who receive anesthesia for procedures outside the Operating Rooms (NORA). No study, so far, has characterized AE in children who receive anesthesia in the operating rooms (ORA) and NORA when anesthesia care is provided by the same team in a consistent manner. Objective/Aim: We used the same patient-specific Quality Assurance questionnaires (QAs), to elucidate incidences of intraoperative reported AE for children receiving anesthesia in NORA and ORA locations. Through multivariate logistic regression analysis, we assessed the association between patient's AE risk and procedure's location while adjusting for American Society of Anesthesiologists (ASA) status, age, and unscheduled nature of the procedure. Methods/Materials: After Institutional Review Board approval, we used returned QAs of patients under 21 years, who received anesthesia from our pediatric anesthesia faculty from May 1 2006 through September 30, 2007. We analyzed QA data on: service location, unscheduled/scheduled procedure, age, ASA status, presence, and type of AE. We excluded QAs with incomplete information on date, location, age, and ASA status. Results: We included 8707 cases, with 3.5% incidence of reported AE. We had 1898 NORA and 6808 ORA cases with AE incidence of 2.5% and 3.7%, respectively. Multivariate regression analysis revealed that patients with higher ASA status or younger age had higher incidence of reported AE, irrespective of location or unscheduled nature of the procedure. The most common AE type, for both sites, was respiratory related (1.9%). Conclusions: Pediatric reported AE incidence was comparable for NORA and ORA locations. Younger age or higher ASA status are associated with increased risk of AE.
引用
收藏
页码:732 / 739
页数:8
相关论文
共 50 条
  • [31] Monitoring clinical trials based on reported adverse events
    van der Holt, R
    van Putten, W
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 100S - 100S
  • [32] Ivermectin adverse events reported to the food and drug administration
    Avila, Maximillian
    Caceres-Munoz, Alba
    Patel, Arpan
    De la Cruz, Pablo Frias
    Mandair, Satpreet
    Young, Amy
    Forrester, Mathias
    CLINICAL TOXICOLOGY, 2022, 60 : 63 - 63
  • [33] Energy drink usage and reported adverse events in adolescents
    Nordt, Sean Patrick
    Claudius, Ilene
    Armijo, Erick
    Milano, Peter
    Yanger, Sheryl
    Rangan, Cyrus
    CLINICAL TOXICOLOGY, 2013, 51 (07) : 633 - 633
  • [34] CARDIOVASCULAR AND CNS ADVERSE EVENTS FOR ANTIDEPRESSANTS REPORTED TO THE FDA
    SPYKER, DA
    CANTILENA, LR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 190 - 190
  • [35] Cannabidiol adverse events reported to the Food and Drug Administration
    Menendez, Anelle
    Hinojosa, Maria
    Jaramillo-Stametz, Jeanie
    Forrester, Mathias B.
    CLINICAL TOXICOLOGY, 2020, 58 (11) : 1177 - 1178
  • [37] Capsaicin adverse events reported to the Food and Drug Administration
    Hogue, Kelly
    Petty, Lizbeth
    Forrester, Mathias B.
    CLINICAL TOXICOLOGY, 2020, 58 (11) : 1148 - 1149
  • [38] Adverse drug events reported by rural older adults
    Shade, Marcia Y.
    Berger, Ann M.
    Chaperon, Claudia
    Haynatzki, Gleb
    Sobeski, Linda
    GERIATRIC NURSING, 2017, 38 (06) : 584 - 588
  • [39] Adverse drug events reported to FDA have increased
    不详
    MOLECULAR THERAPY, 2007, 15 (11) : 1903 - 1903
  • [40] A Narrative Review on Intraoperative Adverse Events: Risks, Prevention, and Mitigation
    Kawa, Nisrine
    Araji, Tarek
    Kaafarani, Haytham
    Adra, Souheil W.
    JOURNAL OF SURGICAL RESEARCH, 2024, 295 : 468 - 476